{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-123880","form_type":"8-K","ticker":"INMB","cik":"0001711754","company_name":"Inmune Bio, Inc.","filed_at":"2025-12-19T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.233068+00:00","generated_at":"2026-05-16T12:35:39.224801+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"INmune Bio enters $65M ATM equity distribution agreement with A.G.P.","bullets":["Up to $65M of common stock may be sold from time to time through A.G.P. as sales agent.","Commission of 3.0% of gross proceeds; Company not obligated to sell any shares.","Shares offered via shelf registration effective Aug 7, 2024, with prospectus supplement dated Dec 19, 2025.","A.G.P. will use commercially reasonable efforts consistent with Nasdaq rules and state/federal law."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-123880","json":"https://secwatch.observer/filing/0001213900-25-123880.json","markdown":"https://secwatch.observer/filing/0001213900-25-123880.md","text":"https://secwatch.observer/filing/0001213900-25-123880.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1711754/000121390025123880/0001213900-25-123880-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1711754/000121390025123880/ea0269963-8k_inmune.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T12:35:39.224801+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}